Literature DB >> 32787373

Modified rehabilitation exercises for mild cases of COVID-19.

Lulu Zha1, Xi Xu1, Dongya Wang1, Guibin Qiao2, Weitao Zhuang3, Shujie Huang4.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by a new Betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently a global pandemic. Gathered clinicopathological evidence in COVID-19 patients shows that alveoli injuries and interstitial changes are the major mechanisms of impaired O2/CO2 exchange. Few rehabilitation exercises concerning COVID-19 patients were reported. Here, we present a modified version of rehabilitation exercises based on the underlying mechanism of the disease to mild cases of COVID-19. These exercises aimed to improve the pulmonary function of patients and ease the expectoration process. Additionally, an essential branch of Traditional Chinese Medicine (TCM) named acupressure was integrated into the exercises to facilitate the recovery and maintenance of pulmonary function.
METHODS: From March 4, 2020 to May 5, 2020, a total of 60 COVID-19 patients who completed the full course of MRE were enrolled in this observational study. The diagnostic and classification criteria were based on the 7th edition of Diagnosis and Treatment Guideline of COVID-19 published by the National Health Commission of the People's Republic of China. We prospectively gathered patients' reported outcomes concerning respiration-related symptoms at four different time points, including: (I) at admission; (II) at the time of hospital discharge; (III) two weeks after discharge; (IV) four weeks after discharge. The reported respiratory symptoms included dry cough, productive cough, difficulty in expectoration, and dyspnea.
RESULTS: In total, 60 confirmed mild COVID-19 cases were enrolled with a median age of 54 years old. The baseline prevalence for dry cough, productive cough, difficulty in expectoration, and dyspnea were 41.7%, 43.3%, 35.0%, and 50.0%, respectively. The pronounced decline in symptom prevalence was recorded over time. Interestingly, four weeks after discharge, we noticed a lower remission rate in productive cough and difficulty in expectoration.
CONCLUSIONS: The modified rehabilitation exercises were retrieved from the Eight-Section Brocade, and are specifically designed for rehabilitation of COVID-19 patients at home or health facilities. Based on current findings on pronouncedly improved remission rate in respiratory symptoms, we recommend the MRE as suitable rehabilitation exercise to smooth respiration and ease the expectoration process in mild COVID-19 cases.

Entities:  

Keywords:  Coronavirus disease 2019 (COVID-19); exercise therapy; rehabilitation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Mesh:

Year:  2020        PMID: 32787373     DOI: 10.21037/apm-20-753

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  10 in total

Review 1.  The effect of exercise rehabilitation on COVID-19 outcomes: a systematic review of observational and intervention studies.

Authors:  Farzin Halabchi; Maryam Selk-Ghaffari; Behnaz Tazesh; Behnaz Mahdaviani
Journal:  Sport Sci Health       Date:  2022-06-28

Review 2.  Appropriate Timing and Type of Physical Training in Patients with COVID-19 for Muscle Health and Quality of Life: A Systematic Review.

Authors:  I Gusti Putu Suka Aryana; Siti Setiati; Ivana Beatrice Paulus; Dian Daniella
Journal:  J Nutr Metab       Date:  2022-06-01

3.  Protocol for a systematic review and meta-analysis of respiratory rehabilitation following intensive care unit discharge for COVID-19 survivors.

Authors:  Dan Wang; Jin Li; Feilong Zhu; Qianqin Hong; Ming Zhang; Min Gao; Wei Chen
Journal:  BMJ Open       Date:  2020-12-08       Impact factor: 2.692

Review 4.  Research progress of traditional Chinese medicine against COVID-19.

Authors:  Wei Ren; Pan Liang; Yue Ma; Qin Sun; Qingrong Pu; Li Dong; Gang Luo; Maryam Mazhar; Jiali Liu; Raoqiong Wang; Sijin Yang
Journal:  Biomed Pharmacother       Date:  2021-02-03       Impact factor: 7.419

5.  General practitioners should provide the cardiorespiratory rehabilitation' 'minimum advice' for long COVID-19 patients.

Authors:  Wafa Benzarti; Emna Toulgui; Christian Prefaut; Karim Chamari; Helmi Ben Saad
Journal:  Libyan J Med       Date:  2022-12       Impact factor: 1.657

6.  Effect of qigong exercise and acupressure rehabilitation program on pulmonary function and respiratory symptoms in patients hospitalized with severe COVID-19: a randomized controlled trial.

Authors:  Shu-Ting Liu; Chao Zhan; Yun-Jing Ma; Chao-Yang Guo; Wei Chen; Xiao-Ming Fang; Lei Fang
Journal:  Integr Med Res       Date:  2021-10-29

Review 7.  Current state of research about acupuncture for the treatment of COVID-19: A scoping review.

Authors:  Chen Chen; Jie Zhan; Hao Wen; Xiaojing Wei; Lu Ding; Chenyang Tao; Cui Li; Peiming Zhang; Yuyuan Tang; Jingchun Zeng; Liming Lu
Journal:  Integr Med Res       Date:  2021-10-14

8.  The efficacy and safety of self-administered acupressure on respiratory tract infection in chronic kidney disease: a randomized controlled trial.

Authors:  Meifang Liu; Hongqin Sheng; Jiahui Huang; Meiling Xuan; Wenwei Ouyang; Yanmei Zhang; Shuzhen Zhou; Lu Zeng; Lizhe Fu; Yin Chen; Xinyi Huang; Kaiqi Huang; Yifan Wu; Xusheng Liu; Lei Zhang
Journal:  Ann Transl Med       Date:  2022-06

Review 9.  Developing Pulmonary Rehabilitation for COVID-19: Are We Linked with the Present Literature? A Lexical and Geographical Evaluation Study Based on the Graph Theory.

Authors:  Augusto Fusco; Luca Padua; Daniele Coraci; Claudia Loreti; Letizia Castelli; Cosimo Costantino; Antonio Frizziero; Elisabetta Serafini; Lorenzo Biscotti; Roberto Bernabei; Silvia Giovannini
Journal:  J Clin Med       Date:  2021-12-09       Impact factor: 4.241

Review 10.  Providing rehabilitation to patients recovering from COVID-19: A scoping review.

Authors:  Marina B Wasilewski; Stephanie R Cimino; Kristina M Kokorelias; Robert Simpson; Sander L Hitzig; Lawrence Robinson
Journal:  PM R       Date:  2021-10-07       Impact factor: 2.218

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.